Literature DB >> 18667674

Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn's disease.

John K Marshall1.   

Abstract

Entities:  

Year:  2008        PMID： 18667674     DOI： 10.1136/ebm.13.4.115

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  1 in total

Review 1.  Use of the tumor necrosis factor-blockers for Crohn's disease.

Authors:  Alan B R Thomson; Milli Gupta; Hugh J Freeman
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.